Caricamento...
iRECIST: how to do it
BACKGROUND: iRECIST for the objective monitoring of immunotherapies was published by the official RECIST working group in 2017. MAIN BODY: Immune-checkpoint inhibitors represent one of the most important therapy advancements in modern oncology. They are currently used for treatment of multiple malig...
Salvato in:
| Pubblicato in: | Cancer Imaging |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6942293/ https://ncbi.nlm.nih.gov/pubmed/31900236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40644-019-0281-x |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|